A-887826-d8 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

The labelled analogue of a structurally novel, potent and voltage-dependent Nav1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats

A-887826-d8 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

A-887826-d8 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15402	60
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	45000	58
Biosynth Biological Technology (Suzhou) Co Ltd	--	sales@biosynth.com	China	6051	58
Santa Cruz Biotechnology Inc	--	scbt@scbt.com	China	6594	58

---

• A-887826-d8
• 5-(4-Butoxy-3-chlorophenyl)-N-[[2-(4-Morpholinyl-d8)-3-pyridinyl]Methyl]-3-pyridinecarboxaMide
• 5-(4-butoxy-3-chlorophenyl)-N-[[2-(2,2,3,3,5,5,6,6-octadeuteriomorpholin-4-yl)pyridin-3-yl]methyl]pyridine-3-carboxamide
• 1794753-88-0
• C26H29ClN4O3
• Aromatics
• Heterocycles
• Intermediates & Fine Chemicals
• Isotope Labelled Compounds
• Neurochemicals
• Pharmaceuticals